Defense system in the biliary tract against bacterial infection
about
Expression of cytokine and chemokine mRNA and secretion of tumor necrosis factor-alpha by gallbladder epithelial cells: response to bacterial lipopolysaccharidesCurrent diagnosis and treatment of benign biliary strictures after living donor liver transplantationAdvances in cholangiocyte immunobiologyEndoscopic palliation for pancreatic cancerTLR4 promotes Cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis.Biliary innate immunity: function and modulation.What are the risk factors for acute suppurative cholangitis caused by common bile duct stones?Contrast-free endoscopic stent insertion in malignant biliary obstruction.Isolated microorganisms in plastic biliary stents placed for benign and malignant diseases.Risk factors of organ failure in cholangitis with bacteriobiliaInfluence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts.Extended Spectrum-β-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis.Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute CholangitisBiliary complications in liver transplantation: Impact of anastomotic technique and ischemic time on short- and long-term outcome.Air cholangiography in endoscopic bilateral stent-in-stent placement of metallic stents for malignant hilar biliary obstruction.Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia.Pleiotropic roles of bile acids in metabolism.Management of Biliary Strictures After Liver TransplantationBiliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome.Interventional radiology: management of biliary complications of liver transplantationCholangiopathy with respect to biliary innate immunity.MICROBIOLOGICAL ANALYSIS OF BILE IN PATIENTS WITH BENIGN AND MALIGNANT BILIOPANCREATIC DISEASES AND ITS CONSEQUENCES.Bacterial Cholangitis, Cholecystitis, or both in Dogs.Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma.Biliary complications in pediatric liver transplantation: Incidence and management over a decade.Diagnostic and therapeutic value of ERCP in acute cholangitis.Acute cholangitis - an update.The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.Experimental foreign-body infection in the biliary tract in rats.Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids Farnesoid X Receptor and Constitutive Androstane Receptor
P2860
Q24793113-AA2A1589-8D06-4F06-BF8A-092361C729EEQ26773218-72012A9D-3FDF-4390-901F-BF257C6A4F56Q27002954-5CC3BC0A-AE95-48F5-A7E8-DAFAD1F9E9EBQ30417304-C8B24136-FA3A-428B-97C4-ED36AF76D861Q30430381-46DDD057-0547-4181-B740-890DA42ED3B0Q34080138-7A01C482-046D-4534-85AC-D8164E3CB34FQ34206690-93329E18-B605-4583-BE29-7984CEAC0B11Q34224899-3422D0ED-0992-465B-8E37-7CC66F476BB5Q34303177-77D141D9-86AF-436E-8A8C-11273339B9A3Q35783932-C4FF88B1-6622-4A5A-9C8E-5190FBE0BB7EQ35941184-C5BE8F8C-906A-42BA-AF5D-C9DBA9D3B45DQ36107458-98A27372-1F37-4EF4-B1CF-3CEDACACFCE5Q36246303-9D7A23A1-F6D4-403B-A4AA-C12962D739D0Q36400858-86F123CB-4B3B-4DF1-A532-CEAD9228C4B7Q36569172-4DBF1129-4CB9-4473-A284-CA521A5123D9Q36715150-E997E847-623F-46EE-A9E2-BEABEFA207F2Q36843966-60D3B4BD-B5B1-48F1-9451-434F54A98456Q37130035-6EBCDD2F-9291-49D6-ADF3-5A4021BAAF5DQ37818539-C909CA8B-F092-4C7E-9349-9B0D61C1E876Q37844420-EBD2ADD6-5BD1-46AB-A51F-9BB2F5E5B973Q38346143-390BF71F-6668-460E-A103-40287744FE58Q40095880-13F333C4-A905-48C9-80EF-9ACA9C75F904Q40104900-FECBD79E-5953-46B6-BF0B-BB60E1CB14ECQ40176263-4AD4F73C-8FD9-43F3-95F5-94A556FDBFB5Q40922195-82184079-B8F2-4DF5-9E94-9C9991FAAB7EQ42571808-610B57DE-E3D1-4004-9F04-E6A22FB84F42Q50349774-EE050C8A-E442-4BFC-92C2-13915E6E88EBQ54535790-278D3940-8B0B-495F-ACA3-BA847BC95D9EQ54613217-21A92ABA-3D5E-4311-9BC1-FE33640C948CQ55441827-E0F7276D-D510-4943-B1A4-D1FE0B83B0FEQ57113962-61EC4FCA-73C5-429B-B9F8-E9A5F9075B50
P2860
Defense system in the biliary tract against bacterial infection
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Defense system in the biliary tract against bacterial infection
@ast
Defense system in the biliary tract against bacterial infection
@en
Defense system in the biliary tract against bacterial infection
@nl
type
label
Defense system in the biliary tract against bacterial infection
@ast
Defense system in the biliary tract against bacterial infection
@en
Defense system in the biliary tract against bacterial infection
@nl
prefLabel
Defense system in the biliary tract against bacterial infection
@ast
Defense system in the biliary tract against bacterial infection
@en
Defense system in the biliary tract against bacterial infection
@nl
P2093
P356
P1476
Defense system in the biliary tract against bacterial infection
@en
P2093
E A Shaffer
J W Costerton
P2888
P304
P356
10.1007/BF01296423
P407
P577
1992-05-01T00:00:00Z
P6179
1000679064